- IOF International
- IOF Websites
- IOF Microsites
- Member Societies
- - Albania
- - Algeria
- - Argentina
- - Armenia
- - Australia
- - Austria
- - Bahrain
- - Belarus
- - Belgium
- - Bolivia
- - Bosnia and Herzegovina
- - Brazil
- - Bulgaria
- - Cameroon
- - Canada
- - Chile
- - China
- - Colombia
- - Costa Rica
- - Croatia
- - Cuba
- - Cyprus
- - Czech Republic
- - Denmark
- - Dominican Republic
- - Ecuador
- - Egypt
- - Estonia
- - Finland
- - France
- - Georgia
- - Germany
- - Greece
- - Guatemala
- - Hong Kong
- - Hungary
- - Iceland
- - India
- - Indonesia
- - Iran, Islamic Republic of
- - Iraq
- - Ireland
- - Israel
- - Italy
- - Japan
- - Jordan
- - Kazakhstan
- - Kenya
- - Korea, Republic of
- - Kuwait
- - Latvia
- - Lebanon
- - Libya
- - Lithuania
- - Luxembourg
- - Macedonia, Republic of
- - Malaysia
- - Malta
- - Mexico
- - Moldova
- - Morocco
- - Netherlands
- - New Zealand
- - Nigeria
- - Norway
- - Pakistan
- - Palestinian Territory, Occupied
- - Panama
- - Peru
- - Philippines
- - Poland
- - Portugal
- - Puerto Rico
- - Romania
- - Russian Federation
- - Saudi Arabia
- - Singapore
- - Slovakia
- - Slovenia
- - South Africa
- - Spain
- - Sri Lanka
- - Sweden
- - Switzerland
- - Syrian Arab Republic
- - Chinese Taipei
- - Thailand
- - Tunisia
- - Turkey
- - Ukraine
- - United Arab Emirates
- - United Kingdom
- - United States
- - Uruguay
- - Uzbekistan
- - Venezuela
- - Viet Nam
- - Serbia
- Sign In
- Sign Up
- Members Area
The International Osteoporosis Foundation (IOF) website lists osteoporosis guidelines from around the world. Inclusion of national or regional guidelines in this listing does not imply endorsement. Please note that the listing may not be up to date, and there may be multiple guidelines from any one country or region.
Individual references are numbered below and the complete reference list available here.
If your country or region has issued osteoporosis guidelines which are not included here, or if updated guidelines are available, please contact us.
| Country or Region | Title of Guideline | Date |
|---|---|---|
| Europe | European guidance for the diagnosis and management of osteoporosis in postmenopausal women (ref. 26) | 2013 |
| Austria | Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose (ref. 2) | 2003 |
| Belgium | Evidence-based guidelines for pharmacological treatment of postmenopausal osteoporosis a consensus (and other consensus statements: (ref. 68) | 2010 |
| Bulgaria |
Recommendations for good clinical practice in osteoporosis (ref 53) |
2013 |
| Czech Republic |
Diagnosis and treatment of postmenopausal osteoporosis / |
2015 2016 |
| Denmark | National Osteoporosis Guidelines (ref 4) | 2013, revised 2016 |
| Estonia | Title to follow (ref. 32) | 2008 |
| Finland | Osteoporosis prevention and treatment guidelines for health professionals & patients (ref 55) |
2014/2015 |
| France |
Actualisation 2012 des recommandations françaises du traitement médicamenteux de l'ostéoporose post-ménopausique |
Updated 2012 (expected update in 2017) |
| Germany | DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose (ref 6) |
2006/2009 Updated 2014 |
| Greece | Guidelines for the Diagnosis and Management of Osteoporosis in Greece / Cost-effective osteoporosis treatment thresholds in Greece (ref 7) |
2011/ 2015 |
| Hungary | National Guidelines of the Hungarian Society for Osteoporosis and Osteoarthrology (HSOO) (ref 34) | 2006 |
| Italy | Guidelines for the diagnosis, prevention and treatment of osteoporosis (ref. 8) | 2009 |
| Linee guida per la diagnosi, prevenzione e terapia dell’osteoporosi SINOSSI (ref 35) | 2006 | |
| Latvia | National Guidelines for the Diagnostics, Prevention and Treatment of Osteoporosis and other guidelines (ref 56) |
2006-2012 |
| Lithuania | Guideline for osteoporosis diagnosis and treatment (ref 36) | 2011 |
| Netherlands | Richtlijn Osteoporose en fractuurpreventie derde herziening (ref 10) | 2011 |
| Norway | Faglige retningslinjer for forebygging og behandling av osteoporose og osteoporotiske brudd (ref 51) | 2005 |
| Poland |
Guidelines for the diagnosis and management of osteoporosis in Poland. 2017 update (ref. 24) |
2017 |
| Portugal | Recommendations for the diagnosis and treatment of osteoporosis (ref 37) | 2007 |
| Slovakia |
Slovak Rep. Ministry of Health Guidelines for the Diagnosis and Treatment of Patients with Osteoporotic Fractures Slovak Rep. Ministry of Health Guidelines for the Diagnosis and Treatment of Osteoporosis |
2011
|
| Slovenia | Guidelines for the detection and treatment of osteoporosis (ref 38) | 2013 |
| Spain | Sociedad Espanola de Investigaciones Óseas Y Metabolismo Mineral – SEIOMM. Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. (ref 11) |
2014 (3rd version) |
| Sweden | National Guidelines for Musculoskeletal Diseases (incl. osteoporosis) (ref 39) | 2015 |
| National guidelines for management of hip fractures; Treatment recommendations from the MPA (ref 39) | 2003 / 2007 | |
| Switzerland | Osteoporosis Recommendations from the Swiss Association against Osteoporosis (SVGO/ASCO) (ref_69 ) | 2015 |
| United Kingdom | Osteoporosis Clinical guideline for prevention and treatment (NOGG) (ref 12) | 2008 |
| Royal College of Physicians/Bone and Tooth Society/National Osteoporosis Society: Prevention and treatment of glucocorticoid-induced osteoporosis (ref 13) | 2002 | |
| Scotland | Scottish Intercollegiate Guidelines Network: Prevention and management of hip fracture in older people (ref 14) | 2009 |
| Scottish Intercollegiate Guidelines Network: Management of osteoporosis and the prevention of fragility fractures (ref 15) | 2015 |